World Journal of Pharmaceutical
Science and Research

A Global Platform for Open Access, Peer-Reviewed, and Indexed Research in the
Pharmaceutical and Medical Sciences


Login | Registration


ISSN: 2583-6579


Impact Factor: 5.111

ABSTRACT

A REVIEW ON BENEFICIAL PHARMACOKINETIC INTERACTIONS IN ENHANCING BIOAVAILABILITY OF POORLY PERMEABLE DRUGS

Dr. Botta Gayathri*, Dr. S. Niveditha, K. Hetrina Ruth, V. Jokesh, Ch. Varshitha, N. Reddy Yamini and Sk. Anisa

Pharmacokinetic interactions between drugs and other co-administered substances—such as additional drugs or food components—can significantly influence drug absorption, distribution, metabolism, and excretion (ADME). While often viewed as a source of adverse effects or therapeutic failure, certain drug-drug and drug-food interactions can result in beneficial pharmacokinetic outcomes that enhance therapeutic efficacy and safety. These interactions may be harnessed to improve bioavailability, extend plasma half-life, or reduce dosing frequency for drugs with narrow therapeutic windows or poor oral absorption. Beneficial drug-drug interactions can occur when one agent inhibits metabolic enzymes (e.g., cytochrome P450 isoforms) or efflux transporters (e.g., P-glycoprotein), thereby increasing the systemic exposure of a co-administered drug. For anti-retroviral drugs, the drug called ritonavir is used as an pharmacokinetic enhancer. Similarly, drug-food interactions—such as co-administration of high-fat meals with lipophilic drugs (e.g., posaconazole or fenofibrate)—can enhance absorption by improving solubilization and gastrointestinal retention. Citrus fruits like grapefruit inhibit intestinal CYP3A4, potentially increasing drug concentrations of certain statins or calcium channel blockers. Mechanistically, these interactions may involve enzyme inhibition, transporter modulation, or membrane permeability enhancement. When clinically predictable and well-managed, such interactions can be used to reduce drug costs, improve patient adherence, and increase therapeutic response. This shows the positive potential of selected pharmacokinetic drug-drug and drug-food interactions. Understanding these mechanisms allows clinicians and pharmacists to optimize drug therapy through evidence-based use of co-administered agents and dietary strategies.

[Full Text Article]

TRACK ARTICLE

NEWS

  • Impact Factor Increased

    We are pleased to inform you that our IMPACT FACTOR has increased from 3.454 to 5.111

    Email & SMS Alert

    We will provide you email alerts regarding New Issue Release, Publication of your Article, Invitaion for New Upcoming Issue, Manuscript releted Emails etc.

    January 2026 Issue Now Available

    January 2026 Issue is now available online for readers and contributors. Kindly check it on Click here

    Indexing

    This journal is indexed in world wide reputed commettee like: "DOI for all Articles" "Google Scholer" "SJIF Impact Factor:- 5.111" "Cosmos Impact Factor" "ISI Indexing" "International Impact Factor Services (IIFS)" "ResearchBib" etc.

    Upcoming Issue (2026)

    The journal invites researchers, academicians, and scholars to submit their original research articles, review papers, and case studies for the upcoming January 2026 Issue . All submissions will undergo a standard peer-review process.